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Background: Care of patients with diabetes often occurs in the context of other chronic illness. Competing disease
priorities and competing patient-physician priorities present challenges in the provision of care for the complex
patient. Guideline implementation interventions to date do not acknowledge these intricacies of clinical practice. As
a result, patients and providers are left overwhelmed and paralyzed by the sheer volume of recommendations and
tasks. An individualized approach to the patient with diabetes and multiple comorbid conditions using shared
decision-making (SDM) and goal setting has been advocated as a patient-centred approach that may facilitate
prioritization of treatment options. Furthermore, incorporating interprofessional integration into practice may overcome
barriers to implementation. However, these strategies have not been taken up extensively in clinical practice.
Objectives: To systematically develop and test an interprofessional SDM and goal-setting toolkit for patients with
diabetes and other chronic diseases, following the Knowledge to Action framework.
Methods:
1. Feasibility study: Individual interviews with primary care physicians, nurses, dietitians, pharmacists, and patients
with diabetes will be conducted, exploring their experiences with shared decision-making and priority-setting,
including facilitators and barriers, the relevance of a decision aid and toolkit for priority-setting, and how best to
integrate it into practice.
2. Toolkit development: Based on this data, an evidence-based multi-component SDM toolkit will be developed.
The toolkit will be reviewed by content experts (primary care, endocrinology, geriatricians, nurses, dietitians,
pharmacists, patients) for accuracy and comprehensiveness.
3. Heuristic evaluation: A human factors engineer will review the toolkit and identify, list and categorize usability
issues by severity.
4. Usability testing: This will be done using cognitive task analysis.
5. Iterative refinement: Throughout the development process, the toolkit will be refined through several iterative
cycles of feedback and redesign.
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Discussion: Interprofessional shared decision-making regarding priority-setting with the use of a decision aid toolkit
may help prioritize care of individuals with multiple comorbid conditions. Adhering to principles of user-centered
design, we will develop and refine a toolkit to assess the feasibility of this approach.
Keywords: Shared decision-making, Priority setting, Patient decision aid, Interprofessional care, Diabetes mellitus,
Patient education, Medical informatics, Toolkit development, Study protocol, User-centred design, Qualitative methodsBackground
Prevention of diabetes complications requires a multitude
of self-management tasks which are time-consuming. For
example, following the American Diabetes Association
recommendations for self-management would take 143
minutes per day [1]. Patients spend a mean of 58 minutes
per day on self-care, with the largest barrier to additional
care being ‘not enough time’ [1]. To compound this, the
majority (56%) of people with diabetes have two or more
additional chronic conditions [2]. Patient adherence to
clinical practice guideline (CPG) recommendations is im-
pacted by multi-morbidity, as it directly impacts self-
management ability (e.g., depression) [3] and competes for
time and attention [4] (Yu CH: Impact of a web-based
self-management intervention for patients with type
2 diabetes on self-efficacy, self-care and diabetes distress,
submitted). For example, patients with a greater overall
number of comorbidities placed lower priority on diabetes,
had worse diabetes self-management ability [5,6] and poor
cardiometabolic control [7]. Patients with a greater num-
ber of comorbidities also valued longevity and quality of
life (e.g., reduction in complications) [8,9]. In contrast, pri-
mary care physicians prioritized glycemic control, blood
pressure control, and lipid lowering over interventions
such as retinal and renal screening [10]. In one study
where primary care physicians were mailed a clinical vi-
gnette of a patient with diabetes whose main issue was
worsening chronic low back pain, only 44% of physicians
prioritized pain as the primary issue [11]. Thus, competing
disease priorities and competing patient-physician prior-
ities present challenges in the provision of care for the
complex patient.
To help patients and providers reach goals in man-
aging multiple risk factors, effective shared decision-
making (SDM) tools, or decision aids, are needed to
facilitate prioritization of treatment options. SDM con-
sists of patients and providers establishing an ongoing
partnership in exchanging information; deliberating on
options; and deciding upon the priority for taking action
and acting on the decision [12]. Though initially devel-
oped for use in acute care contexts, it has been adapted
for use in chronic care, including diabetes [13]. SDM has
the potential to improve patient care. A systematic review
of randomized controlled trials of SDM identified 11
studies [14]; interventions included an interactive videoprogram, question/information sheet, or card-ranking
discussion. Of the five studies that examined physical and
psychological wellbeing, two studies reported positive
outcomes; both were characterized by long-term deci-
sions that occurred over more than one session in the
setting of chronic disease, thereby indicating a role for
SDM in complex diabetes care.
Mediating factors to the successful implementation of
SDM have been reported. In a review of 38 studies [15],
the most common barriers were time constraints, and
lack of applicability due to patient characteristics and
his/her clinical situation. Facilitators of SDM included pro-
vider motivation, having a positive impact on clinical
process and outcome [16], healthcare provider training,
and patient-mediated interventions [17]. Specific to dia-
betes, patients have reported that patient/provider power
imbalance, health literacy and denial of the condition were
barriers to SDM. Provision of medical knowledge, valid-
ation of patient experiences, strong interpersonal skills,
and provider availability were facilitators of SDM [18].
These barriers to SDM can be overcome by incorpor-
ating IP care providers. Furthermore, diabetes care may
occur in the context of interprofessional (IP) care [19],
defined as promotion of high-quality care through syner-
gistic efforts of multiple healthcare professionals’ [20-23].
Several systematic reviews in diabetes care have shown that
role expansion, active participation by more than one dis-
cipline, and the addition of new healthcare team members
[24-26] improve clinical outcomes. In addition to improv-
ing clinical parameters, incorporating an IP approach may
facilitate uptake of SDM [27].
SDM can be facilitated by the use of patient decision
aids (PtDAs) [17,28,29], as they help frame the decision
to be made. A 2011 Cochrane review of PtDAs [30]
identified 86 studies and found that PtDAs improved de-
cision quality and process, and that detailed PtDAs were
more effective than simpler PtDAs [31]. Furthermore,
when the PtDA was used within the consultation with
the healthcare practitioner, patients were more likely to
achieve SDM with their practitioner when compared to pa-
tients using a PtDA on their own [31,32]. In a search of the
published literature, we identified four PtDAs focusing on
diabetes, one evaluated with a prospective observational
study [33], and three evaluated through randomized con-
trolled trials [34-37]. These PtDAs included a goal-setting
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Choice’ [34-36,39], and a ‘Metabolic control’ aid [37].
These were studied in specialty clinics [33-36], primary
care [38,39] and general public [40]. While knowledge, risk
perception, satisfaction, decision-making participation,
trust, decisional conflict, and documented goals improved,
there was no impact on diabetes empowerment nor clinical
outcomes; effect on adherence was mixed. With the excep-
tion of one tool [33], these PtDAs focused on one specific
decision (such as the decision to initiate lipid-lowering
therapy) and did not specifically address patient-important
priorities and decisions. However, potential exists for their
use in setting healthcare goals and prioritizing disease
management strategies in patients with diabetes and
other comorbidities [33]. Corser et al. (2007) has set
the precedent with a brief SDM goal-setting intervention
in an American primary care clinic [33]. This intervention
consisted of a 28-page patient workbook, a 2-hour patient
education session and two 2-hour medical resident semi-
nars. Post-intervention knowledge increased significantly
(P = 0.001), as did a number of documented diabetes goals
(pre: 0.67 goals; post: 1.09 goals; P <0.001). Glycemic con-
trol, weight, and diabetes empowerment scores showed a
trend toward improvement. While this study was limited
by its observational nature, it suggests a role for SDM in
goal-setting in patients with diabetes. We anticipate that
effectiveness can be further optimized with the additional
provision of a point-of-care tool for use at the time of
consultation and a provider-specific tool, to be used
longitudinally, and with more explicit integration of the
interprofessional team.
We hypothesize that a multi-component PtDA toolkit
(patient-directed, provider-directed and point-of-care
tools) that individualizes care priorities and incorpo-
rates an IP approach to SDM may help to prioritize com-
plex guideline recommendations for patients with type 1
or type 2 diabetes and other comorbidities. Therefore, such
a tool may improve the relevant uptake of the Canadian
Diabetes Association (CDA) 2013 CPG [41] into practice.
Methods
This study will be guided by the Knowledge to Action
(KTA) framework [42] to develop, test and refine a
multi-component IP-SDM toolkit designed to help
prioritize guideline-based disease management in patients
with multimorbidity, defined as those with type 1 or
type 2 diabetes and additional chronic conditions. In the
KTA framework, knowledge is created, refined, then ap-
plied through seven iterative steps. This model is appro-
priate for the systematic development and evaluation of
our intervention as it allows for close integration of re-
searchers and knowledge-users, systematic and iterative
intervention development, rigorous evaluation and sus-
tainability. In this protocol, we outline the first four steps(Table 1). We also integrated the Medical Research
Council framework for the development and evaluation
of complex interventions [42], as it provides additional
rigour regarding complex interventions, defined as those
that entail numerous interacting components, numerous
behaviours required, numerous groups targeted, or nu-
merous outcomes [42]. This combined model is appro-
priate for the systematic development and evaluation of
this intervention [43].
Study overview
The study detailed in this protocol paper consists of four
phases: feasibility testing (Phase 1); toolkit development
(Phase 2); heuristic evaluation (Phase 3); and usability
testing (Phase 4). Throughout the development process,
the toolkit will be refined iteratively based on findings of
each phase.
This program of research will continue with a rigorous
evaluation of the effectiveness of the PtDA toolkit. Our
intent is to conduct a two-step clustered RCT (Phase 5).
Phase 1. Feasibility testing
This phase will consist of assessing the feasibility of IP-
SDM. Individual semi-structured interviews with health-
care providers and patients (60 to 75 minutes long)
will be used to explore their experiences with shared
decision-making and priority setting, including facilita-
tors and barriers, the relevance of a decision aid and tool-
kit for priority-setting, how best it would be integrated
into practice and potential content of the PtDA [44].
After exploring these concepts, participants will work
through a prototypic PtDA (Additional file 1), setting pri-
orities for diabetes management with the interviewer pro-
viding scripted responses as the ‘patient’ or ‘provider.’
Participants
A purposive sampling strategy will be adopted to ensure
sample heterogeneity (in order to capture the perspec-
tives of healthcare providers and patients with varied
clinical and life experiences) [45].
A total of 20 family physicians with varied socio-
demographic profiles (age, gender, remuneration plan,
academic vs. community) and 13 to 15 nurses, dietitians
and/or pharmacists (either certified diabetes educators or
not) with varied profiles (age, gender, academic vs. com-
munity) will be recruited through family health teams
in the academic and community settings in the Greater
Toronto Area.
A total of 13 to 15 patients with type 1 or type 2 dia-
betes and two other comorbidities (heart disease [includ-
ing ischemic, valvular, congestive, arrhythmic, congenital
disease]; stroke; hypertension; cancer [excluding non-
melanoma skin cancer]; chronic lung disease; arthritis,
inflammatory bowel disorders; urinary incontinence) with
Table 1 Knowledge to Action framework
Steps KTA framework Relevance to study proposal
1 Identify review and select knowledge Knowledge has been refined into a high quality CPG [41], and there is an evidence to practice gap
(Background). We have identified the existing evidence regarding individualization of care and SDM
in an IP context, and the IP-SDM framework on which to build our intervention (Background).Identify problem
2 & 3 Adapt knowledge to local context The MOHLTC’s Ontario Diabetes Strategy aimed to improve the care of Ontarians with diabetes
through access to technology, specialized resources and health professionals, to enable patients
and providers to actively co-manage, monitor and improve care. New education teams (nurse
educators and dietitians) were created to help support people with diabetes in primary care; thus
our use of the IP-SDM framework complements this context. Having identified barriers to CPG and
SDM uptake (Background) in the literature, we will identify barriers in our targeted population by
conducting (Phase 1), the feasibility substudy (Methods).
Assess barriers to knowledge use
4 Select, develop and tailor the
intervention
Based on potential facilitators of SDM adoption identified in the literature [17] (Background), a
previously reported goal-setting intervention [33] (Discussion) and the findings of Substudy 1, our
IP-SDM intervention will be developed (Phase 2). Subsequently, we will then conduct heuristic
evaluation (Phase 3) and usability testing (Phase 4).
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tainment) in these Family Health Teams will be identified
through their healthcare providers or chart review. We se-
lected these conditions because of their chronic nature,
high prevalence [2] and impact on self-management.
Patients who do not speak English or who are unable to
provide consent will be excluded. Women who are preg-
nant or considering conception will be excluded.
A sample size of 13 participants per group (10 initial
interviews with 3 subsequent interviews to ensure no
new themes emerging) will likely be necessary to achieve
saturation and to generate sufficient feedback to refine
the toolkit [46]. We are proposing to recruit a greater
number of physicians to account for additional demo-
graphic strata as mentioned above.
Data collection
One-on-one interviews with patients and providers will
be based on interview guides developed by team mem-
bers with expertise in qualitative research and SDM. We
will focus on mediators to PtDA adoption and appropri-
ateness of content and formats used (Additional file 2:
Phase 1 Interview Guide). Healthcare provider inter-
views will be conducted at their practice site or by tele-
phone; patient interviews will be conducted at our
research site or by telephone. We will use open-ended
questions based on pre-existing literature regarding bar-
riers and facilitators to SDM and goal-setting [17,18] and
the Theoretical Domains framework [40]. This framework
includes constructs from 33 behavior change theories and
was developed to make theories more accessible to imple-
mentation researchers. We selected this approach because
it has good construct validity and has been widely applied
in healthcare implementation research [47]. The partici-
pant will also use a decision-aid prototype, created by the
principal investigator with content from evidence-based
guidelines [41] and an International Patient Decision Aid
Standards checklist [48] with the interviewer substitutingthe role of the healthcare provider for patient interviews
or patient for healthcare provider interviews with scripted
responses. Face validity of this guide will be assessed with
other team members and refined as needed; we will test
the instrument on team members, including knowledge
user team members (such as primary care physicians,
nurse, and person with diabetes) before conducting inter-
views. A trained interviewer will conduct each interview
session. All individual interviews will be audio taped and
field notes will be kept of all interviews.
Analysis
Audiotapes will be transcribed to create a verbatim tran-
script. In keeping with qualitative methodology, data
analysis will occur in conjunction with data collection.
Ongoing analysis will inform the development of pro-
gressive iterations of the interview guides. Inductive
thematic analytic techniques will be employed [49-51].
Transcripts will be coded for emergent categories and
themes within and across interviews [44]. All transcripts
will be coded and reviewed independently by two team
members with expertise in qualitative research methods.
Consensus on coding will be reached through compari-
son and discussion among these reviews. Memos kept by
the qualitative team members will help monitor the ana-
lysis, and regular meetings will enable continued dia-
logue and discussion within the project. NVivo software
(v.10) will be used for analysis.
Phase 2. Toolkit development
Based on potential facilitators of SDM adoption identi-
fied in the literature [17], a previously reported goal-
setting intervention [33] and the findings of Phase 1, the
IP-SDM toolkit will be developed.
Development of the toolkit will rely on the IP-SDM
framework [52] and follow the International Patient
Decision Aids Standards criteria [48]. The International
Patient Decision Aids Standards provide explicit guidance
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IP-SDM framework consists of seven steps in SDM and
considers the role of the patient, the family and the health-
care team [53]. Content of our toolkit will include: eliciting
the patient’s general priorities of care; eliciting his/her
diabetes-specific goals and outcomes; outlining diabetes-
specific therapies and detailing population-specific benefits
and risks. We will select the content based on the evidence
underlying the CPG recommendation as well as patient
values elucidated in Phase 1. Use of the IP-SDM toolkit
within the team will be fluid and dependent on the usual
roles, responsibilities and processes of care and the needs
of the patient. The initial IP-SDM toolkit will be in the
English language; the patient-directed components will tar-
get a Grade 8 literacy level (readability score) [48].
Following development, the PtDA will be reviewed by
expert healthcare providers and patients not involved in
the development process for content accuracy. The re-
search team will identify two each of family physicians, en-
docrinologists, geriatricians, nurses, dietitians, pharmacists
and patients. Reviewers will complete a report to deter-
mine the PtDA’s accuracy, comprehensiveness, balance
of perspective, and ease of understanding (Additional
file 3). Data from the report form will be collated and an-
alyzed descriptively; any discordant responses between
reviewers will be discussed and resolved by the research
team. Revisions to the toolkit content will be made based
on this feedback.
Phase 3. Heuristic evaluation
This phase will consist of heuristic evaluation, in which
a human factors engineer, following the methodology
set out by Nielsen [37,51,53,54], will review the PtDA.
Usability issues will be identified, listed, then categorized
by severity into minor, moderate, major or catastrophic;
severity estimates will be based on frequency, impact and
persistence of errors.
Based on these findings, the IP-SDM toolkit will be
refined in an iterative fashion by study team members,
including a graphics designer and computer programmer,
as necessary.
Phase 4. Usability testing
Usability testing using cognitive task analysis [55], whereby
users are individually asked to ‘think aloud’ as they perform
specific tasks to cover the major functionalities of the
IP-SDM toolkit (provider enabler, PtDA and patient work-
book) will be conducted in a 60- to 75-minute session.
Participants
A consecutive sample of 16 patient-provider dyads will
be invited to participate. We will first recruit health
care providers (eight primary care physicians, and eight
nurses, dietitians and/or pharmacists). We will use aconvenience sample of healthcare providers of varied
socio-demographic profiles (described in Phase 1) recruited
from family practice units at academic health science and
community centers in the Greater Toronto Area. We will
ask each provider participant to identify a patient with dia-
betes who will be invited by our research coordinator. We
will try to ensure a sampling of patients with type 1 or type
2 diabetes and two other comorbidities with varied socio-
demographic profiles (described in Phase 1). Research has
shown that up to 80% of usability issues can be identified
through five to eight participants [55]. We anticipate con-
ducting up to three usability cycles of four to five partici-
pant dyads in a process of iterative redesign.
Data collection
A consultant with expertise in health informatics and
human factors engineering will conduct each session in
the primary care or research setting. After a brief over-
view of the process, the consultant will prompt users
with a structured interview guide with regards to usabil-
ity. Paths users take to accomplish tasks, errors made,
when and where they encountered confusion or frustra-
tion, and time spent on the PtDA toolkit or individual
tasks within the PtDA toolkit will be documented. Follow-
ing completion of the task, participants will be interviewed
regarding degree of satisfaction, strengths and weaknesses
of the toolkit, and the quality of decision support given by
the provider to the patient. All interviews will be audio-
taped. Field notes will be kept of all sessions as a further
source of data for analysis.
Analysis
Data analysis will be conducted as described in Phase 1.
Audiotapes will be analyzed independently by two members
of the research team to assess knowledge use (i.e., did SDM
occur for each patient-provider dyad) using a validated
scale, the Decision Support Analysis Tool (DSAT-10) [56].
DSAT-10 evaluates practitioners’ use of decision support
during a clinical encounter. It consists of six categories of
decision support skills and four categories of communica-
tion skills. The overall inter-rater agreement and kappa co-
efficients were, respectively 75% and 0.59 for the decision
support skills, and 76% and 0.68 for the communication
skills. Disagreement will be resolved by discussion. A de-
scriptive analysis of the numerical data will be performed.
Based on these findings, the IP-SDM toolkit will be re-
fined in an iterative fashion, after four to five interviews.
Research ethics
The study was approved by the Research Ethics Boards
of St. Michael’s Hospital (reference number 13-014C),
Sunnybrook Health Sciences Health Centre (reference
number 345–2013) and Women’s College Hospital (refer-
ence number 2013–0058).
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We are commencing recruitment at study sites.
Discussion
Diabetes is a complex disease, often associated with mul-
tiple other conditions. Competing disease priorities and
competing patient-physician priorities present challenges
in the provision of care for the complex patient, thereby
reducing guideline adherence. Adopting a patient-centered
SDM model of care, wherein the patient sets goals and
management priorities with the support of healthcare pro-
viders, has the potential to improve uptake of patient-
relevant guideline recommendations, improve the process
of care and patient-important outcomes such as quality of
life. Our objective is to systematically develop, test and
refine a diabetes-focused SDM and priority-setting PtDA
following the KTA framework [32].
While SDM and the use of PtDAs hold promise, suc-
cessful implementation would require good quality PtDAs
targeting the users’ needs with careful attention to devel-
opment [48], effective mechanisms and formats to deliver
it in clinical care [30], and models to support their imple-
mentation in clinical practice [31]. We will address these
factors in our project.
Study strengths include our systematic evidence-based
and user-centered development and implementation,
enabled by team expertise and knowledge-user engage-
ment. The team includes expertise in shared decision-
making, knowledge translation, information technology,
primary care diabetes, and qualitative and quantitative
research methods, as well as key knowledge users –
primary care providers and people with diabetes.
Study limitations include potential volunteer bias and
recruitment. To address volunteer bias, we will compare
socio-demographic characteristics of participants and
non-participants. Successful recruitment and implemen-
tation will depend on strong knowledge user engage-
ment, which we have developed by creating a combined
knowledge user-researcher team.
Competing health concerns present real obstacles to
people living with diabetes and other chronic disease
and their primary care providers. Guideline implementa-
tion interventions to date do not acknowledge these
impediments, and as a result, patients and providers are
left overwhelmed by the sheer volume of recommenda-
tions. Shared decision-making regarding priority-setting
with the use of PtDAs may help focus care of these indi-
viduals. An interprofessional approach to SDM may also
overcome the barriers to implementation of the PtDA
such as time, availability and perceived power imbalance.
Adhering to principles of user-centered design, this tool-
kit will be developed and refined to assess the feasibility
of this approach. Given the growing prevalence of diabetes
and multimorbidity, effectively bridging the knowledge topractice gap in this area has the potential to significantly
improve patient-important outcomes, healthcare delivery
and system sustainability.
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